Source comparison
Best Tesamorelin + Ipamorelin Blend Dosage Visceral Fat 2026: Protocol Comparison
This table compares the three most commonly referenced Tesamorelin + Ipamorelin protocols in current literature, based on 2026 clinical and observational data. | Protocol | Tesamorelin Dose | Ipamorelin Dose | Administration Timing | Observed VAT Reduction (26
This comparison does not assign a generated winner or score.
- This table compares the three most commonly referenced Tesamorelin + Ipamorelin protocols in current literature, based on 2026 clinical and observational data.
- | Protocol | Tesamorelin Dose | Ipamorelin Dose | Administration Timing | Observed VAT Reduction (26 weeks) | Receptor Desensitisation Risk | Professional Assessment ||—|—|—|—|—|—|| Standard Evening Protocol | 2mg daily | 300mcg daily | Both injected 9–11 PM, Ipamorelin 30–45 min before Tesamorelin | 15.2–18.4% | Moderate (cycle off at week 26) | Evidence-supported standard. Synchronises with nocturnal GH pulse, manageable desensitisation timeline || Morning Fasted Protocol | 2mg daily | 300mcg daily | Both injected upon waking, 3+ hours fasted | 12.8–14.6% | Moderate-High (earlier plateau) | Suboptimal. Morning cortisol spike interferes with GH signalling, lower VAT reduction vs evening dosing || Split-Dose Protocol | 1mg twice daily | 150mcg twice daily | Morning and evening doses, 12 hours apart | 10.2–13.1% | High (rapid receptor downregulation) | Not recommended. Split dosing accelerates desensitisation without improving outcomes, logistically complex |